Non–Small Cell Lung Cancer | FDA-Approved Therapy Option
SponsoredLearn of an Option After Surgery and Chemotherapy for Certain Patients With NSCLC. Read More on the Official Patient Site.IMFINZI® (durvalumab) | HCPs: View The POSEIDON Study
SponsoredView Data From The POSEIDON Study To Learn About The IMFINZI Indication. Access Trial Data To See If IMFINZI Combination Treatment Is An Option For Your Patients.
Related Products
Some results have been hidden because they may be inaccessible to you.Show inaccessible results
New NSCLC Treatment Option | Resectable NSCLC Patients
SponsoredLearn About A New Resectable NSCLC Treatment Option For Before & After Surgery. A New Treatment May Be An Option For Your Or A Loved One With Resectable NSCLC.New Clinical Study Data · Mechanism Of Action Info · Dosing & Administration